Gentiva

Gentiva
Name	Gentiva
Type	Public (former)
Industry	Health care industry
Fate	Acquired by Kindred Healthcare
Founded	1999 (as Gentiva Health Services)
Headquarters	Nashville, Tennessee
Key people	Sean D. Slovenski (former CEO), Diane K. Brannin (former CFO)
Services	Home health, hospice, home infusion
Revenue	$2.1 billion (2013)

Gentiva was an American provider of post-acute care and home health services that operated national networks of home health, hospice, and home infusion businesses. The company expanded through acquisitions and organic growth during the 2000s and early 2010s, serving Medicare and private-pay patients across the United States. Gentiva's operations intersected with major trends in Medicare reimbursement, consolidation in the health care industry, and the shift toward community-based care.

History

Gentiva originated in the late 1990s as a consolidation of regional home health providers and was publicly listed following an initial public offering tied to the spin-off of community care assets from larger corporate parents. Management pursued roll-up strategies similar to those executed by Kindred Healthcare, Encompass Health, and Amedisys. Through the 2000s the company acquired local agencies in markets such as California, Florida, Texas, and New York to build scale and geographic coverage. Gentiva's timeline included key corporate events associated with regulatory shifts under Centers for Medicare & Medicaid Services payment reforms and responses to policy changes stemming from Balanced Budget Act of 1997 implications for home health. Leadership transitions and strategic refocusing punctuated its growth, aligning with trends seen at peers like LHC Group and Almost Family.

Services and Operations

Gentiva provided three principal service lines: home health nursing and therapy, hospice and palliative care, and specialty home infusion services. Its home health offerings included skilled nursing, physical therapy, occupational therapy, and speech-language pathology, comparable to services offered by Visiting Nurse Service of New York and agencies participating in Medicare home health benefit programs. Hospice operations delivered end-of-life care in private residences, nursing facilities, and inpatient hospice centers, mirroring standards from organizations such as National Hospice and Palliative Care Organization. The home infusion business supplied parenteral nutrition, antimicrobial therapy, and complex biotherapeutics in the home setting, similar to providers like Option Care Health and Coram Healthcare. Operations were organized regionally, with clinical oversight, quality programs, and compliance functions designed to meet licensure requirements in states including California, Texas, and New York and accreditation standards from bodies comparable to The Joint Commission.

Corporate Structure and Management

Gentiva was governed by a board of directors and an executive leadership team responsible for clinical operations, compliance, finance, and corporate development. Executives with experience at national health companies and private equity-backed platforms influenced strategy, as seen in leaders who formerly worked at organizations like Kindred Healthcare and HCA Healthcare. The company maintained corporate offices in Nashville, Tennessee and field management in regional hubs. Its corporate structure incorporated centralized functions for revenue cycle management, human resources, and information technology, and used regional management to oversee thousands of clinicians, administrators, and support staff dispersed across multiple states. Compensation and governance policies followed public-company norms under Securities and Exchange Commission reporting and Sarbanes–Oxley Act requirements.

Financial Performance

During its public tenure Gentiva reported revenues in the low billions, with notable year-to-year variability tied to reimbursement policy, caseload mix, and acquisition activity. Financial disclosures reflected revenue drivers such as Medicare home health utilization, hospice census growth, and margins in the home infusion unit. The company pursued cost-savings initiatives and integration synergies after acquisitions, seeking to improve operating margins in an environment comparable to peers like Amedisys and Encompass Health. Gentiva's stock performance and credit metrics were influenced by investor response to changes in Centers for Medicare & Medicaid Services rules, shifts in referral patterns from hospital systems and physician groups, and competitive dynamics in community-based care markets.

Controversies and Legal Issues

Like many large home health and hospice operators, Gentiva faced regulatory scrutiny and legal challenges related to billing, documentation, and compliance with Medicare conditions of participation. Enforcement actions and investigations by agencies analogous to the Office of Inspector General (United States Department of Health & Human Services) and civil litigants raised issues over reimbursement practices and recordkeeping. The company engaged in settlements and corrective action plans to resolve claims alleging improper billing or inadequate documentation, paralleling matters experienced by other industry participants such as Amedisys and Kindred Healthcare. Lawsuits and contractual disputes with former executives, vendors, or acquisition targets also appeared episodically in its corporate record.

Acquisition and Legacy

In 2014 Gentiva agreed to be acquired by Kindred Healthcare in a transaction that combined Gentiva's home health, hospice, and home infusion businesses with Kindred's post-acute services. The acquisition reflected the consolidation trend among national providers seeking scale to manage Medicare reimbursement risk and coordinate transitions of care with hospital partners such as HCA Healthcare, Community Health Systems, and regional health systems. Post-acquisition, Gentiva's brand was subsumed into the acquiring company's platform, but its operational practices and clinical models influenced industry standards for home-based care. The deal contributed to reshaping the national landscape of post-acute services alongside other consolidation events involving firms like Encompass Health and Amedisys.

Category:Health care companies of the United States